Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Advania on its offer for Caperio Holding
Mandate

Vinge advises Advania on its offer for Caperio Holding

April 27, 2017

Advania has, through Advania Holding AB, made a recommended cash offer to the shareholders of Caperio Holding AB (publ) (Nasdaq First North).

The offer values all shares of Caperio at SEK 158 million.

Vinge advises Advania. The Vinge team is headed by Peter Sundgren and Dain Hård Nevonen and also includes Rikard Lindahl, Malte Hedlund, Peter Issa and Annika Nyberg Ekenberg (on M&A matters), as well as Lova Unge (on compensation and benefits matters), Caroline Krassén (on regulatory matters), Marie Östman and Anna Grigorian (on competition matters).

Related

Vinge advises Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun

 Vinge is advising Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun from Dalafast. The acquisition comprises four properties with a total of 23,200 square metres of retail space, which together constitute Tallen’s largest retail area.
November 11, 2026

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026